Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 2.644 a 2.663 di 26.012
Titolo Data di pubblicazione Autore(i) File
BEVACIZUMAB BEYOND PROGRESSION: HOW TO MONITOR TREATMENT EFFICACY? RESULTS OF A FUNCTIONAL IMAGING STUDY IN MURINE COLORECTAL CANCER 1-gen-2012 Heijmen, L; Ter Voert, Eegw; Punt, Cja; De Geus-Oei, L; Heerschap, A; Bussink, J; Zerbi, V; Oyen, W; Boerman, O; van Laarhoven, Hwm
Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: a single-arm Phase 2 study. 1-gen-2014 Santoro, A; Hillerdal, G N; Hoeffken, G; Favaretto, A; Carrion, R P; Visseren-Grul, C; Ameryckx, S; Helsberg, K; Soldatenkovav, ; Bourayou, N; Sorensen, N J
Bevacizumab Improves Pathologic Response and Protects against Hepatic Injury in Patients Treated with Oxaliplatin-based Chemotherapy for Colorectal Liver Metastases 1-gen-2007 Ribero, D; Wang, H; Donadon, M; Zorzi, D; Thomas, Mb; Eng, C; Chang, Dz; Hamilton, Sr; Ellis, Lm; Curley, Sa; Abdalla, Ek; Vauthey, J-N
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 1-gen-2008 De Sanctis, R; Cerbone, L; Sacco, Pc; Sollami, R; Fulvi, A; Petrelli, E; Girolami, M; Bianco, V; Longo, F; Di Seri, M
Bevacizumab prevents effective targeting of anti-epidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies 1-gen-2012 Heskamp, S; van Laarhoven, Hwm; Molkenboer-Kuenen, Jdm; van der Graaf, Wta; Oyen, W; Boerman, Oc
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies 1-gen-2013 Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; van der Graaf, Wta; van Laarhoven, Hwm
Bevacizumab treatment reduces targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies 1-gen-2012 Heskamp, S; van Laarhoven, H; Molkenboer-Kuenen, J; Oyen, W; van der Graaf, W; Boerman, O
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study 1-gen-2021 Daniele, G; Raspagliesi, F; Scambia, G; Pisano, C; Colombo, N; Frezzini, S; Tognon, G; Artioli, G; Gadducci, A; Lauria, R; Ferrero, A; Cinieri, S; De Censi, A; Breda, E; Scollo, P; De Giorgi, U; Lissoni, Aa; Katsaros, D; Lorusso, D; Salutari, V; Cecere, Sc; Zaccarelli, E; Nardin, M; Bogani, G; Distefano, M; Greggi, S; Piccirillo, Mc; Fossati, R; Giannone, G; Arenare, L; Gallo, C; Perrone, F; Pignata, S
Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response 1-gen-2016 Cesca, M; Morosi, L; Berndt, A; Nerini, If; Frapolli, R; Richter, P; Decio, A; Dirsch, O; Micotti, E; Giordano, S; D'Incalci, M; Davoli, E; Zucchetti, M; Giavazzi, R
Bexarotene and interferon-alpha combination therapy in a patient affected by relapsing anaplastic large cell lymphoma with cutaneous involvement 1-gen-2007 Ardigo, M; Marulli Georgiana Clare, ; Carlo, Cota; Antonio, Mastroianni; Enzo, Berardesca
Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival 1-gen-2022 Moroni, Gabriella; Porata, Giulia; Raffiotta, Francesca; Quaglini, Silvana; Frontini, Giulia; Sacchi, Lucia; Binda, Valentina; Calatroni, Marta; Reggiani, Francesco; Banfi, Giovanni; Ponticelli, Claudio
BEYOND PALLIATION: USING EUS-GUIDED CHOLEDOCHODUODENOSTOMY WITH A LUMEN-APPOSING METAL STENT AS A BRIDGE TO SURGERY 1-gen-2019 Fabbri, C; Fugazza, A; Binda, C; Zerbi, A; Jovine, E; Cennamo, V; Repici, A; Anderloni, A
Beyond Palliation: Using EUS-Guided Choledochoduodenostomy with a Lumen-Apposing Metal Stent as a Bridge to Surgery. A Case Series 1-gen-2019 Fabbri, C; Fugazza, A; Binda, C; Zerbi, A; Jovine, E; Cennamo, V; Repici, A; Anderloni, A
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? 1-gen-2017 Biondi, G.; Sotgiu, G.; Dore, S.; Molicotti, P.; Ruggeri, M.; Aliberti, S.; Satta, R.
Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy 1-gen-2009 Desar, Ime; van Herpen, Cml; van Laarhoven, Hwm; Barentsz, Jo; Oyen, W; van der Graaf, Wta
Beyond remission and mucosal healing in Crohn's disease. Exploring the deep with cross sectional imaging 1-gen-2017 Maconi, G; Armuzzi, A
Beyond semantic: the need to better categorie patients with cancer. 1-gen-2013 Tralongo, P; Annunziata, M A; Santoro, A; Tirelli, U; Surbone, A
Beyond stillness: the importance of tackling patient's motion for reliable parametric imaging 1-gen-2024 Artesani, Alessia; Providência, Laura; van Sluis, Joyce; Tsoumpas, Charalampos
Beyond the Epiretinal Membrane: Depth of Traction and Intraretina Angio-OCT Changes 1-gen-2016 Romano, Mario R.
Beyond the epiretinal traction in diabetic interface: The Muller cell and GFAP protein 1-gen-2016 Romano, Mario R.
Mostrati risultati da 2.644 a 2.663 di 26.012
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile